Konferenzen  >  Medizin & Gesundheitswesen  >  Pharmakologie und Arzneimittelentwicklung

ComplianceOnline

In this two half-day workshop conference you will learn how GMP applies directly to virtual company operations, how to best structure a quality management system in a virtual company, and a method to decide which procedures are necessary at what points in time. You will also learn best practices for quality agreements and vendor management. In addition, you will learn the current guidance from FDA for application of GMP to the manufacture of Phase 1, 2 and 3 clinical trial materials. Though FDA requirements are the primary emphasis, some discussion of EMA (European) requirements and other venues will also be included.

phase appropriate gmp, fda gmp workshop, FDA GMP Expectations, Phase I, First-in-Man Clinical Trials, CMC Requirements, IND Study, Raw Material Management, 505(b)(2) Products process Validation, ISO 9001:2015 QMS, Combination Products

Biotechnologie,    Legislation in der Medizin und Pharmakologie

Uventia Global

The 6th Extractables & Leachables Summit 2026 is a premier two day event bringing together global experts from pharma, biotech, medical devices and regulatory agencies to discuss the latest trends, challenges and innovations in E&L science.

Email: info@uventia.com

Global Regulatory Frameworks & Harmonization, Packaging and Route Specific Risks, Biologics and Secondary Leachables, E&L in Medical Devices & Their Risk Assessment, Single Use Systems & Process Equipment, Sustainability in E&L Testing, Digitalization & AI Modeling in E&L, Lifecycle Integration of E&L Strategies

Legislation in der Medizin und Pharmakologie,    Massenspektrometrie, Chromatographie und Kernspinresonanzspektroskopie

FDAMap

SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.

FDA, SOPs, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Translationale Medizin, Klinische Studien

Virtue Insight

This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 40th Pharmacovigilance UK & EU 2026. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.

Tel.: [+44 2035093779];     Email: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

FDAMap

In the field of regulatory affairs, professionals often encounter the task of writing complex documents for diverse audiences. These documents encompass a wide range, including reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and various communication documents. The purpose of this exclusive technical writing workshop is to provide regulatory professionals with valuable insights into best practices and regulatory strategies for crafting effective documents. The workshop will cover a spectrum of writing needs, from simple issues like minutes of meetings and correspondence notes to more intricate tasks such as producing comprehensive nonclinical and clinical study reports, as well as regulatory submissions to regulatory bodies such as FDA, EMA, Health Canada, and others.

FDA, ​Technical Writing, Regulatory Writing, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Translationale Medizin, Klinische Studien

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The vaccine development pipeline is a time, cost and labour-intensive process. Mathematical and computational methods can alleviate challenges related to this intensive process as well as providing further insights into the efficacy and safety of vaccines. These methods are key components of model-informed vaccine development (MIVD) and quantitative systems pharmacology/toxicology (QSP/T). MIVD and QSP/T can be used in tandem to better understand the biological processes and outcomes from vaccination administration, spurring future research. This workshop will strengthen and contribute to the ongoing development of this interdisciplinary community of biologists, mathematicians and vaccinologists.

Angewandte Mathematik (allgem.),    Simulation

American Society for Experimental Neurotherapeutics (ASENT)

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where leaders from providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders & innovation centers gather to improve the process of bringing neurotherapeutics to market.

Tel.: [8332731556];     Email: jessica@asent.org

Neurology, Neurotherapeutics, Neuroscience, Biotech, Bioengineering, FDA, NIH, Drug Development, Pipeline Presentations

Develop / review a company's Master Validation Plan for major cGMP deficiencies. Address the U.S. FDA's newer and tougher regulatory stance.

verification and validation training seminar, V&V product equipment software QMS training, FDA verification and validation best practices course, master validation plan development webinar, risk-based V&V planning training, product verification and validation compliance seminar, equipment and process validation course, software validation webinar for regulated industries, QMS validation and 21 CFR Part 11 training, risk-based approach to V&V workshop, V&V project management seminar, ISO 14971 and ICH Q9 V&V risk management course, develop V&V files and protocols training, V&V planning and documentation workshop, DQ IQ OQ PQ validation techniques seminar, validation protocols for production equipment course, software V&V 11-element FDA requirements session, QMS electronic records and e-signatures validation webinar, V&V change control implementation seminar, validation case studies and templates training, regulated industry validation best practices seminar, pharmaceutical and medical device V&V course, diagnostics and biologics V&V training, compliance with FDA and EU validation standards, validation audit readiness training, V&V roles and responsibilities for QA and regulatory affairs, process and software validation fundamentals, monitoring and test equipment validation training, V&V milestone and task planning course, V&V in resource constrained environments training, validation test case and script construction workshop, GAMP-based validation planning seminar, lean validation documentation course, cloud and ERP system V&V training, senior management V&V strategic workshop, validation risk assessment and hazard analysis training, validation checklist and templates seminar, quality system validation essentials training, regulatory compliance for verification and validation, product quality verification workshop, validation sample size justification training.

Legislation in der Medizin und Pharmakologie,    Pharmakogenomik, Personalisierte Medizin

BOC Sciences

March 23rd, 2026 10:00 EDT

This webinar, featuring Prof. Nikolai Petrovsky, explores how recent research and tools like artificial intelligence are unlocking the broad pharmaceutical utility of polysaccharides, using inulin as a key case study.

Event Administrator;     Email: account@bocsci.com

Chemistry and properties of polysaccharides; Research tools for polysaccharides; Solving polysaccharide structures using AI; Pharmaceutical utility of polysaccharides;

ComplianceOnline

One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes did not adversely impact products, processes, equipment, facilities, etc. A single inadequate change may lead to significant negative events, including release of sub-standard product or product recall. A pattern of inadequate changes may require costly and time-consuming system remediation efforts.

FDA change control training seminar, change control best practices workshop, FDA change control expectations course, pharmaceutical change control compliance training, change control regulatory requirements USA, FDA-focused change control program training, virtual seminar for change control professionals, change control risk assessment training, GMP change control training online, FDA documentation and change control compliance, best practices for FDA change control in pharma manufacturing, how to comply with FDA change control requirements 2026, step-by-step change control process training seminar, change control risk assessment and execution webinar, pharmaceutical quality systems change control workshop, change proposal and justification training for regulated industry, document control vs equipment change control seminar, change control plan documentation best practices course, avoiding common FDA 483 citations change control strategies, critical thinking for successful change control implementation, FDA warning letter examples change control, risk-based change management in biotech, change execution plan templates, change control inspection readiness training, integrated change control process model, change control for validation engineers, regulatory filings for major manufacturing changes, change control in medical device environments, change control accreditation certificate course, FDA compliance checklist for change control, pharmaceutical quality compliance training, FDA 483 inspection change control deficiencies, change impact assessment best practices, quality management system change control, supplier and material change control strategies, like-for-like change controls, emergency change control guidelines, change control documentation package, subject matter expert change review, process validation and change control integration, FDA inspection readiness change control, change control warning letter prevention, how to write change proposals for FDA compliance, change justification risk assessment methods, executing and implementing regulated manufacturing changes, QMS and change control integration, training for validation staff change control, change control for QA QC teams, engineering and production management change control training, regulatory compliance seminar for pharmaceutical professionals, biotech change control training program, medical device change management compliance course

ComplianceOnline

Good Manufacturing Practices (GMP) describe the requirements for manufacturing drug product in each country or region and cover areas such as facility design and sanitation, product testing, product identification, equipment, packaging, warehousing and distribution, and recordkeeping. These requirements include the required education, training and experience for employees whose activities affect the quality of drug products. Among those educational requirements are a course in Introductory GMP upon employment at a pharmaceutical company, and annual refresher GMP training.

good manufacturing practices seminar, GMP compliance training online, current good manufacturing practices course, GMP regulatory requirements workshop, FDA and international GMP best practices seminar, pharmaceutical manufacturing GMP training, GMP quality systems and compliance course, risk management in GMP environment training, GMP facility and HVAC control seminar, raw materials and supplier management GMP training, deviation investigation and CAPA under GMP, annual product review and GMP compliance seminar, contamination control and cleanroom GMP workshop, GMP documentation and record keeping training, personnel competency and GMP requirements course, process control and production GMP seminar, equipment and utilities GMP compliance training, quality assurance GMP fundamentals webinar, GMP inspection readiness training, cGMP pharmaceutical industry workshop, global GMP standards training, GMP training for QA/QC professionals, GMP training for operations managers, GMP risk assessment and mitigation seminar, regulatory audit readiness GMP course, drug and biologics GMP compliance webinar, GMP certification preparation training, quality management and SOPs under GMP requirements, GMP case studies and examples seminar, contamination prevention and control best practices, GMP for medical device manufacturing, compliant manufacturing processes workshop, GMP training for supply chain professionals, GMP training for regulatory affairs teams, advanced cGMP principles course.

Legislation in der Medizin und Pharmakologie,    Pharmakogenomik, Personalisierte Medizin

ELETS Technomedia

The expo will be taking place at Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat) 2026, With the concurrent events Next Gen Pharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies, Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Tel.: [09560050693];     Email: indiapharmaexpo1@gmail.com

Pharamaceuticals, Healthcare Technologies, Vaccines, Nanotechnology, Smart Molecule

Messen und Ausstellungen,    Medizintechnik

The expo will be taking place t Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat). 2026, with the concurrent events NextGenPharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies,Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Project Head;     Tel.: [95600 50693];     Email: milan.jena@elets.in

healthcare, science, pharmaceuticals, biotenchnology, nenotechnology, health

The objective of this on-line, interactive two day "Essentials of USP Microbiology" seminar is to explore USP General and General Information Chapters to learn their current and updated status and to confirm that those Chapters being utilized are used correctly.

USP microbiology chapters seminar, essentials of USP microbiology training, USP general and information microbiology course, pharmaceutical microbiology compliance webinar, USP microbiological examination of nonsterile products training, USP microbiology sterility test seminar, bacterial endotoxins test training, antimicrobial effectiveness testing course, USP microbial control and monitoring HVAC training, microbiological raw material testing seminar, API microbiology testing and control workshop, USP microbial characterization and identification training, application of water activity in microbiology, validation of microbial recovery training, sterile and non-sterile microbiology chapter interpretation, harmonization USP EP JP microbiology requirements, objectionable and specified microorganisms seminar, pharmaceutical HVAC microbial environment course, FDA 483 microbiology inspection readiness, microbiological best lab practices webinar, bioburden control seminar, microbial contamination control in pharmaceutical manufacturing, microbiology for QA QC regulatory professionals, microbiological environmental monitoring training, USP microbiology general info test methods, endotoxin and sterility assurance course, pharmaceutical microbiology documentation and SOP seminar, non-sterile product microbial testing course, controlled vs classified environment microbiology training, raw material bioburden sampling criteria workshop, microbiology course for regulatory affairs, aseptic processing microbiological control training, microbial risk assessment in pharmaceutical environments, USP microbiology harmonization training, HVAC microbial contamination control seminar, microbial compliance strategies for APIs and raw materials.

Biotechnologie,    Legislation in der Medizin und Pharmakologie

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The landscape of drug design is rapidly evolving, with computational methods and artificial intelligence (AI) playing an increasingly important role. This workshop aims to explore cutting-edge mathematical approaches that are transforming the field of computational drug design. We will delve into multiscale modeling techniques that bridge the gap between molecular and macroscopic levels, providing a comprehensive understanding of drug interactions and dynamics. Additionally, we will highlight the integration of generative AI and machine learning (ML) algorithms in predicting drug efficacy, optimizing molecular structure, speeding up drug repurposing, understanding potential toxicity, and thus accelerating the drug discovery and development process. By bringing together diverse experts from academia, industry, and innovation support organizations, and adding early career researchers to the mix, this workshop will foster interdisciplinary collaboration and innovation. Participants will gain insights into the latest developments, discuss challenges, and explore future opportunities in the quest for more effective and efficient drug design.

Angewandte Mathematik (allgem.),    Neuronale Netze und Künstliche Intelligenz, Maschinelles Lernen

UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the UK and the world.

Head of Partnerships & Business Development;     Tel.: [+443301338933‬];     Email: jane.smith@ukbiotechday.org

pharmaceutical industry events, pharma, biotech, biotech conferences, Pharma conferences, pharma biotech conferences, pharma biotech dealmaking conferences, pharma business development and licensing conference, pharma congress, pharmaceuticals, Biotech events, Pharma Events, Pharma Partnering, Partnering Conference, Business Development Conference, Licensing Conference, BD&L Conference, Pharma Deals, Biotech Deals, Pharma-Biotech Deals, R&D Collaborations, Conference, Networking, Event, Europe, Life Sciences, pharmaceuticals, pharma, biotech

Biotechnologie,    Legislation in der Medizin und Pharmakologie

Uventia Global

From Fundamentals to Lifecycle Control in a High-Scrutiny Environment

Email: info@uventia.com

We Will Talk About Regulatory Expectations & Inspection Trends. Equipment Design & Cleanability Studies. Cleaning Validation Protocols & Documentation: Inspection-Ready in 2026. Analytical & Microbiological Methods for Cleaning Validation. Cleaning Validation Lifecycle Approach. Visual Inspection as a Contamination Control Tool. Cleaning process development and cleaning agent selection. Limit setting and visual clean – how does this fit together? Risk-Based Cleaning Validation in Complex Facilities. Cleaning Validation Failures & Troubleshooting. Continuous Process Verification, Automation & Digitalisation. Case Studies & Industry Best Practices.

Biochemie und Medizinische Chemie, Toxikologie,    Chemikalien und Materialwissenschaft

Creovate Conferences

At Creovate Conferences, we believe scientific gatherings should be more than lectures—they should ignite collaboration, drive innovation, and influence global health and regulatory policy. That’s the core vision behind the International Conference on Toxicology and Applied Pharmacology (Toxicology2026), taking place from May 28–30, 2026, in the vibrant city of Barcelona, Spain.

International Conference on Toxicology and Applied Pharmacology;     Email: toxicology@creovateconferences.com

Toxicology Applied Pharmacology Drug Toxicity Clinical Toxicology Experimental Pharmacology Pharmacokinetics and Pharmacodynamics Molecular Toxicology Environmental Toxicology Occupational Toxicology Forensic Toxicology Analytical Toxicology Pharmacological Research Neurotoxicology Immunotoxicology Genetic Toxicology Reproductive and Developmental Toxicology

Innovinc International

Tel.: [+14084650048];     Email: brian.mitchell@pharmanext.org

Pharma Conferences Czech Republic, Medical & Pharma Events in Prague - Czech Republic, Digital Healthcare Conference, Annual Global Pharmacovigilance Summit, Pharmaceutical Conferences, Pharmaceutical events, Drug Delivery Conferences, Clinical Pharmacy, Medical and pharma events Prague, International Conference on Pharmacy and Pharmacology, Pharma Care, Pharma Research Events, Global Biopharmaceutical Events, Pharma Research Conferences in Europe 2026, PharmaWorld Congress, Innovative Pharma Horizons, PharmaBridge Global Meet, Global Pharma Connect, Pharma Frontiers Summit, NextGen Pharma Conference 2026, Evidence to Excellence Conference, Pharma Safety Event 2026, Pharma Trials, Molecule to Medicine Summit, Pharmacology of Infectious Diseases Conferences 2026, Pharmacology Conferences, Clinical Pharmacology, Drug synthesis and Formulation event, International Summit on Toxicology and applied Pharmacology, International Congress of Toxicology 2026, Pharmaceutical sciences Conferences, Nanotechnology Conferences, International Conference on Nanotechnology, PBPK Modelling and Simulation, Novel Targets in Pharmacology & Drug Discovery, World Congress on Pharmacology & Therapeutics, Global Summit on Clinical & Experimental Pharmacology, International Conference on Drug Development & Pharmacodynamics, Cancer Pharmacology & Chemotherapy Advances, Pharmacokinetics & Pharmacodynamics Workshop, Pediatric & Geriatric Pharmacology Summit, oxicology & Environmental Pharmacology Meet, Immunopharmacology & Biologics Symposium, Neuropharmacology & Psychopharmacology Summit, Cardiovascular & Metabolic Pharmacology Congress, Novel Targets in Pharmacology & Drug Discovery, International Conference on Drug–Drug Interactions & Therapeutics, Global Summit on Pharmacokinetics and Drug Interactions, Clinical Pharmacology Forum, Advances in Drug Interaction Science & Safety, Symposium on Predictive Models in Drug–Drug Interactions.

Magnus Group LLC

Rome, Italy welcomes the 13th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2026), scheduled for September 14-16, 2026, with virtual access for worldwide participants. With “Advancing Pharmaceutics: From Formulation to Patient Impact” as its foundation, PDDS 2026 fosters global dialogue and innovation in advancing pharmaceutics.

Tel.: [07029882320];     Email: luciana.phar@gmail.com

Kenes Exhibitions

Join us for the 3rd RNA Horizons Conference, taking place September 16–18, 2026, in Munich, Germany. This premier event brings together scientists, clinicians, and biotech innovators to explore the latest advancements in RNA therapeutics, spanning established modalities as well as emerging areas such as ASOs and RNA structure–based therapies. Discussions will cover key trends, including pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will focus on translating discoveries into viable therapies, with insights into commercialization and market access.

Tel.: [972 747457435];     Email: skrein@kenes-exhibitions.com

RNA therapeutics, RNA biology, RNA medicine, RNA delivery, antisense oligonucleotides, self-amplifying RNA, RNA-based therapy, cancer research, oncology innovation, RNA stability, clinical translation, biotechnology, life sciences, European biotech, Horizon Europe, CANCERNA consortium, Hadassah Cancer Research Institute, RNA Horizons, RNA conference Europe, Munich 2026, RNA innovation, European research collaboration

Biotechnologie,    Translationale Medizin, Klinische Studien

Magnus group

Join us at the 6th Edition of International Vaccines Congress (IVC 2026) happening from October 05–07, 2026 in Tokyo, Japan, designed to expand knowledge and progress in the field of vaccinology. The event offers an excellent learning environment where global experts will discuss innovative vaccine platforms, regulatory advancements, and immunization outreach. Professionals from academia, industry, testing laboratories, and public health sectors will collaborate to solve challenges in vaccine access, safety, and efficacy. IVC 2026 supports scientific exchange that inspires stronger research outcomes and a healthier future through vaccination.

Tel.: [7029882320];     Email: ChristieSimpson.IVC@gmail.com

Vaccines Conferences 2026 | Vaccine Development Congress Japan | Immunology Conferences 2026 | International Vaccines Congress | Vaccine Delivery Systems Conference | mRNA Vaccine Platforms Event | Immunotherapeutics Summit | Biopharmaceutical Vaccine Innovation Forum | Global Immunization Strategies Conference | Pandemic Preparedness and Vaccination Event | Clinical Trials and Vaccine Safety Meeting | Viral and Bacterial Vaccines Symposium

STEM Network

Welcome to the Pharma & Pharmacology Conference 2026, focusing on developments in pharmaceutical sciences and health care in the presence of industry and health from across the globe.

Mary Ann;     Tel.: [+1 (872) 2138-777];     Email: pharma.ppbc@stemnetwork.net

Drug Discovery and Screening, Pharmacogenomics, Drug Metabolism and Toxicology, Drug Design and Discovery, Novel Drug Delivery Systems, Drug Delivery Systems, Inhaled Drug Delivery, Pharmacovigilance and Drug Safety, Bio Chemical Pharmacology

Keystone Symposia

There have been tremendous advances in developing novel nucleic acid-based strategies for treating human diseases. Recent clinical successes have validated nucleic acid-based platforms, documenting that they can provide life-changing medicines to patients who need them. However, efficient delivery of these nucleic acid payloads to the cell type of interest and the appropriate subcellular compartment still limits their full potential despite significant progress over the past decade. This meeting is designed to bring together scientists from multiple disciplines, all working on delivery of nucleic acid cargos to cells. The meeting will cover the latest designs for viral vectors, lipid nanoparticle systems, virus-like particles, and ligand conjugates to enhance delivery of nucleic acid payloads. This meeting is unique in bringing scientists working on these different strategies for drug delivery into a single venue. Although these strategies have the common goal of enhancing intracellular delivery of nucleic acid cargo they tend to be siloed. A key goal of the meeting is to bring scientists together who have different expertise and perspectives to learn from each other, enabling more rapid and effective solutions for these delivery challenges. This will be a joint conference with the genome engineering meeting, which creates a lot of synergies. The genome engineering will discuss various nucleic acid cargo, while this meeting will focus on delivery technologies for the nucleic acid cargo. This meeting will be held jointly with Precision Genome Engineering: From Laboratory to Clinic.

Genetics, Genomics, RNA, Nucleic Acid Therapeutics, Drug Delivery, Gene Therapy, Viral Vectors, Nanoparticles, Translational Research

Molekularbiologie,    Genomforschung und Bioinformatik